VACCITECH PLC

$14.26 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About VACCITECH PLC

Vaccitech plc operates as a clinical-stage biopharmaceutical company. The Company focuses in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Vaccitech serves customers in the United Kingdom.

Stock Analysis

last close $14.26
1-mo return -10.4%
3-mo return -3.4%
avg daily vol. 15.52T
52-week high 17.99
52-week low 12.25
market cap. $503M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $4M
inst own. 10%
baraka

Subscribe now for daily local and international financial news

Subscribe